vs

Side-by-side financial comparison of Danaher Corporation (DHR) and LPL Financial Holdings Inc. (LPLA). Click either name above to swap in a different company.

Danaher Corporation is the larger business by last-quarter revenue ($6.0B vs $4.9B, roughly 1.2× LPL Financial Holdings Inc.). Danaher Corporation runs the higher net margin — 17.3% vs 6.1%, a 11.2% gap on every dollar of revenue. On growth, LPL Financial Holdings Inc. posted the faster year-over-year revenue change (40.4% vs 3.7%). Danaher Corporation produced more free cash flow last quarter ($1.1B vs $613.3M). Over the past eight quarters, LPL Financial Holdings Inc.'s revenue compounded faster (32.0% CAGR vs 1.8%).

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...

LPL Financial Holdings Inc. was founded in 1989 and is considered the largest independent broker-dealer in the United States. As of 2021 the company had more than 17,500 financial advisors, over US$1 trillion in advisory and brokerage assets, and generated approximately $10.3 billion in annual revenue for the 2023 fiscal year. LPL Financial has main offices in Boston, Fort Mill, Austin, and San Diego. The company is a member of FINRA and the SIPC.

DHR vs LPLA — Head-to-Head

Bigger by revenue
DHR
DHR
1.2× larger
DHR
$6.0B
$4.9B
LPLA
Growing faster (revenue YoY)
LPLA
LPLA
+36.8% gap
LPLA
40.4%
3.7%
DHR
Higher net margin
DHR
DHR
11.2% more per $
DHR
17.3%
6.1%
LPLA
More free cash flow
DHR
DHR
$471.7M more FCF
DHR
$1.1B
$613.3M
LPLA
Faster 2-yr revenue CAGR
LPLA
LPLA
Annualised
LPLA
32.0%
1.8%
DHR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DHR
DHR
LPLA
LPLA
Revenue
$6.0B
$4.9B
Net Profit
$1.0B
$300.7M
Gross Margin
60.3%
Operating Margin
22.6%
8.1%
Net Margin
17.3%
6.1%
Revenue YoY
3.7%
40.4%
Net Profit YoY
7.9%
11.1%
EPS (diluted)
$1.45
$3.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHR
DHR
LPLA
LPLA
Q1 26
$6.0B
Q4 25
$6.8B
$4.9B
Q3 25
$6.1B
$4.6B
Q2 25
$5.9B
$3.8B
Q1 25
$5.7B
$3.7B
Q4 24
$6.5B
$3.5B
Q3 24
$5.8B
$3.1B
Q2 24
$5.7B
$2.9B
Net Profit
DHR
DHR
LPLA
LPLA
Q1 26
$1.0B
Q4 25
$1.2B
$300.7M
Q3 25
$908.0M
$-29.5M
Q2 25
$555.0M
$273.2M
Q1 25
$954.0M
$318.6M
Q4 24
$1.1B
$270.7M
Q3 24
$818.0M
$255.3M
Q2 24
$907.0M
$243.8M
Gross Margin
DHR
DHR
LPLA
LPLA
Q1 26
60.3%
Q4 25
58.0%
Q3 25
58.2%
Q2 25
59.3%
Q1 25
61.2%
Q4 24
59.5%
Q3 24
58.7%
Q2 24
59.7%
Operating Margin
DHR
DHR
LPLA
LPLA
Q1 26
22.6%
Q4 25
22.0%
8.1%
Q3 25
19.1%
-0.7%
Q2 25
12.8%
9.6%
Q1 25
22.2%
11.4%
Q4 24
21.8%
9.7%
Q3 24
16.5%
11.2%
Q2 24
20.3%
11.3%
Net Margin
DHR
DHR
LPLA
LPLA
Q1 26
17.3%
Q4 25
17.5%
6.1%
Q3 25
15.0%
-0.6%
Q2 25
9.3%
7.1%
Q1 25
16.6%
8.7%
Q4 24
16.6%
7.7%
Q3 24
14.1%
8.2%
Q2 24
15.8%
8.3%
EPS (diluted)
DHR
DHR
LPLA
LPLA
Q1 26
$1.45
Q4 25
$1.69
$3.65
Q3 25
$1.27
$-0.37
Q2 25
$0.77
$3.40
Q1 25
$1.32
$4.24
Q4 24
$1.50
$3.58
Q3 24
$1.12
$3.39
Q2 24
$1.22
$3.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHR
DHR
LPLA
LPLA
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
$7.3B
Stockholders' EquityBook value
$5.3B
Total Assets
$18.5B
Debt / EquityLower = less leverage
1.36×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHR
DHR
LPLA
LPLA
Q1 26
Q4 25
$1.1B
Q3 25
$1.6B
Q2 25
$4.3B
Q1 25
$1.4B
Q4 24
$1.0B
Q3 24
$1.6B
Q2 24
$1.4B
Total Debt
DHR
DHR
LPLA
LPLA
Q1 26
Q4 25
$18.4B
$7.3B
Q3 25
$16.9B
$7.5B
Q2 25
$17.4B
$7.2B
Q1 25
$16.5B
$5.7B
Q4 24
$16.0B
$5.5B
Q3 24
$17.5B
$4.4B
Q2 24
$17.0B
$4.4B
Stockholders' Equity
DHR
DHR
LPLA
LPLA
Q1 26
Q4 25
$52.5B
$5.3B
Q3 25
$51.1B
$5.0B
Q2 25
$52.3B
$5.1B
Q1 25
$50.8B
$3.1B
Q4 24
$49.5B
$2.9B
Q3 24
$51.3B
$2.8B
Q2 24
$49.9B
$2.5B
Total Assets
DHR
DHR
LPLA
LPLA
Q1 26
Q4 25
$83.5B
$18.5B
Q3 25
$79.9B
$18.0B
Q2 25
$81.6B
$17.5B
Q1 25
$79.1B
$14.0B
Q4 24
$77.5B
$13.3B
Q3 24
$80.6B
$11.9B
Q2 24
$78.6B
$11.5B
Debt / Equity
DHR
DHR
LPLA
LPLA
Q1 26
Q4 25
0.35×
1.36×
Q3 25
0.33×
1.49×
Q2 25
0.33×
1.41×
Q1 25
0.32×
1.82×
Q4 24
0.32×
1.87×
Q3 24
0.34×
1.60×
Q2 24
0.34×
1.77×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHR
DHR
LPLA
LPLA
Operating Cash FlowLast quarter
$1.3B
$785.0M
Free Cash FlowOCF − Capex
$1.1B
$613.3M
FCF MarginFCF / Revenue
18.2%
12.4%
Capex IntensityCapex / Revenue
4.0%
3.5%
Cash ConversionOCF / Net Profit
1.28×
2.61×
TTM Free Cash FlowTrailing 4 quarters
$5.3B
$-981.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHR
DHR
LPLA
LPLA
Q1 26
$1.3B
Q4 25
$2.1B
$785.0M
Q3 25
$1.7B
$-1.7B
Q2 25
$1.3B
$193.3M
Q1 25
$1.3B
$339.8M
Q4 24
$2.0B
$-178.8M
Q3 24
$1.5B
$209.3M
Q2 24
$1.4B
$-178.9M
Free Cash Flow
DHR
DHR
LPLA
LPLA
Q1 26
$1.1B
Q4 25
$1.7B
$613.3M
Q3 25
$1.4B
$-1.9B
Q2 25
$1.1B
$56.3M
Q1 25
$1.1B
$220.3M
Q4 24
$1.5B
$-344.3M
Q3 24
$1.2B
$62.3M
Q2 24
$1.1B
$-307.8M
FCF Margin
DHR
DHR
LPLA
LPLA
Q1 26
18.2%
Q4 25
25.5%
12.4%
Q3 25
22.6%
-41.1%
Q2 25
18.4%
1.5%
Q1 25
18.4%
6.0%
Q4 24
23.0%
-9.8%
Q3 24
21.0%
2.0%
Q2 24
19.7%
-10.5%
Capex Intensity
DHR
DHR
LPLA
LPLA
Q1 26
4.0%
Q4 25
5.4%
3.5%
Q3 25
4.8%
3.1%
Q2 25
4.2%
3.6%
Q1 25
4.3%
3.3%
Q4 24
7.9%
4.7%
Q3 24
5.1%
4.7%
Q2 24
5.0%
4.4%
Cash Conversion
DHR
DHR
LPLA
LPLA
Q1 26
1.28×
Q4 25
1.77×
2.61×
Q3 25
1.83×
Q2 25
2.41×
0.71×
Q1 25
1.36×
1.07×
Q4 24
1.86×
-0.66×
Q3 24
1.85×
0.82×
Q2 24
1.56×
-0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons